×

Actavis plans new Allergan approach: Report

3:05 PM ET Tue, 7 Oct 2014

According to Reuters, Actavis plans to make a new approach for a takeover of Allergan. CNBC's Dominic Chu reports Allergan would be open to sale at a price over $200 a share.